Vascular Surgery Products

A line of products designed to provide a gentle approach to the treatment of vascular inflammation and infections, for care, topical and systemic treatment of ‘Circulatory and microcirculatory failure, venous stasis, edema, of Ulcers and of Diabetic Foot

All products of this line are constituted by an association of active ingredients, and optimal dosages to ensure a rapid therapeutic effect.









RSS Journal of Vascular Surgery

  • Table of contents February 1, 2025
  • Events of Interest February 1, 2025
    News items of interest to the vascular surgeon must be received at least 8 weeks before the desired month of publication. Announcements published at no charge include those received from a sponsoring society of this Journal, those courses and conferences sponsored by state, regional, national, or international vascular surgical organizations, and university-sponsored continuing medical education […]
  • Effect of Family History of Aortic Disease on Outcomes of Fenestrated and Branched Endovascular Aneurysm Repair of Complex Aortic Aneurysms February 1, 2025
    The clinical significance of family history (FH) of aortic disease on the outcomes of fenestrated and branched endovascular aneurysm repair (FB-EVAR) has not been well described. This study aimed to assess how FH of aortic disease affects outcomes following FB-EVAR for complex aortic aneurysms (CAAs).
    T.A.L. Sulzer, T. Mesnard, A. Schanzer, C.H. Timaran, D.B. Schneider, M.A. Farber, A.W. Beck, Y. Huang, G.S. Oderich
  • Role of Multistate Models to Predict Patency, Limb Salvage, and Survival: New Concepts to Analyse Data in Peripheral Arterial Disease February 1, 2025
    In peripheral arterial disease, patency, limb salvage, and survival rates are mostly reported using Kaplan–Meier analyses. When comparing different revascularisation techniques, these methods have limitations in analysing complex patient flows over time. This study aimed to present, illustrate, and discuss new concepts based on multistate models of analysing outcome parameters in peripheral arterial disease.
    W. Hitzl, M. Kluckner, M. Pilz, M. Opperer, K. Linni, P. Nierlich, F.K. Enzmann
  • Systematic review of the effects of topical oxygen therapy on wound healing February 1, 2025
    JVS–Vascular Insights 2024;2:100051. https://doi.org/10.1016/j.jvsvi.2023.100051
    K. Nagarsheth, A. Kankaria, J. Marsella, E. Dunlap, S. Hawkins, A. Ucuzian, B.K. Lal
  • Major Adverse Limb Events in Patients Undergoing Revascularisation for Lower Limb Peripheral Arterial Disease: A Nationwide Observational Study February 1, 2025
    Major adverse limb events (MALEs) are frequent in patients with lower extremity peripheral arterial disease (PAD). However, routine care MALE rate estimations after revascularisation are scarce. This study aimed to determine post-procedural MALE rates in revascularised patients with PAD and identify predictors of post-procedural MALEs.
    V. Amlani, K. Ludwigs, A. Rawshani, M. Thuresson, M. Falkenberg, K. Smidfelt, J. Nordanstig
  • How do we afford the BEST care for females with chronic limb-threatening ischemia? February 1, 2025
    The recent pivotal randomized trial, Best Endovascular vs Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI), will undoubtedly be a landmark study for years to come. The authors solidified the conclusion that patients with an adequate single-segment great saphenous vein (SS-GSV) had lower incidence of major adverse limb events (MALE) or death when […]
    Leigh Ann O’Banion